Skip to main content
Ning Li, MD, Pathology, Stratford, CT

Ning Li MD

Dermatopathology, Anatomic Pathology, Clinical Pathology


Dermatopathologist and pathologists

Join to View Full Profile
  • 200 Watson BlvdStratford, CT 06615

  • Phone+1 203-380-4584

Dr. Li is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Dermatopathology, 2004 - 2005
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2001 - 2004
  • Beijing Medical University
    Beijing Medical UniversityClass of 1987

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2007 - 2027
  • NY State Medical License
    NY State Medical License 2007 - 2027
  • TN State Medical License
    TN State Medical License 2017 - 2027
  • WA State Medical License
    WA State Medical License 2004 - 2027
  • CT State Medical License
    CT State Medical License 2005 - 2026
  • IL State Medical License
    IL State Medical License 2009 - 2026
  • KY State Medical License
    KY State Medical License 2008 - 2026
  • Anatomic Pathology
    American Board of Pathology Anatomic Pathology
  • Dermatopathology
    American Board of Pathology Dermatopathology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Editorial: Material Surfaces and Interfaces at the Nanoscale: From Theory to Application
    Editorial: Material Surfaces and Interfaces at the Nanoscale: From Theory to ApplicationFebruary 3rd, 2021
  • IFI16 Promotes Human Embryonic Stem Cell Trilineage Specification Through Interaction with p53
    IFI16 Promotes Human Embryonic Stem Cell Trilineage Specification Through Interaction with p53October 29th, 2020
  • EpimAb Biotherapeutics Raises $25M in Series A Financing from International Consortium to Advance Pipeline of Novel Bispecific Antibodies
    EpimAb Biotherapeutics Raises $25M in Series A Financing from International Consortium to Advance Pipeline of Novel Bispecific AntibodiesApril 25th, 2017
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: